rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Martine A. Rothblatt

Chairperson & CEO

Company insider

Files Form 4 as: Chairperson & CEO, United Therapeutics; Director, Beta Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
10,481
Buys
36
Sells
1,232
Bought
$16.8M
Sold
$2.6B
Companies
2
Companies where not an officer
1
First trade
12 Jan 2005
Last trade
22 Oct 2026
Last filed
23 Oct 2026

Companies traded

Where they are an officer
UTHR United TherapeuticsDirector, Officer · Biotechnology · last 22 Oct 202636 buys · 1232 sells
Everywhere else they filed: board seats, 10% stakes, other companies
BETA Beta TechnologiesDirector · Aerospace & Defense · last 11 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
250Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Code M$1.1M9,500 at $117.76filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$162K280 at $577.28filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$93K160 at $578.59filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$93K160 at $579.69filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$209K360 at $581.03filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$233K400 at $581.83filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$443K760 at $583.09filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$701K1,200 at $584.21filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$1.0M1,756 at $585.24filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$750K1,280 at $586.31filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$550K937 at $587.24filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$42K74 at $562.97filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$461K783 at $588.19filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$141K240 at $589.50filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$94K160 at $590.40filing
22 Oct 2026filed 23 Oct 2026UTHR United Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code M—9,500 at $0.00filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$62K110 at $563.98filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$90K160 at $565.09filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$91K160 at $570.08filing
22 Oct 2026filed 23 Oct 2026UTHR United TherapeuticsBiotechnologySEC FORM 4 Sold$91K160 at $571.77filing

The newest 500 lines are listed; the numbers count every line.

Sectors

Health Care1268

Buys in green, sells in red, by the company’s sector.

Related people

Paul A. MahonEVP & General Counsel · EVP & General Counsel at United Therapeutics, filing Form 4 there in the last year
Nilda MesaDirector · Director at United Therapeutics, filing Form 4 there in the last year
Victor J. DzauDirector · Director at United Therapeutics, filing Form 4 there in the last year
Christopher PatuskyDirector · Director at United Therapeutics, filing Form 4 there in the last year
Christopher CauseyDirector · Director at United Therapeutics, filing Form 4 there in the last year